.png)
Plasma Fractionation Market by Product, Application and End User - Global Industry Analysis & Forecast to 2027
Published On : August 2019 Pages : 160 Category: Pharma & Healthcare Report Code : HC084852
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Plasma Fractionation Market By Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor), Application (Immunology, Hematology, Critical Care, Rheumatology) and End User (Hospital, Clinic, Academic Institute) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Plasma is a blood segment, got from entire blood by plasmapheresis, and utilized for different remedial and medicinal applications. Human plasma is a wellspring of various proteins, anyway just few of these proteins are valuable for creating remedial plasma items. The procedure of detachment, extraction and purging of these proteins from the plasma is called as fractionation process.
Drivers and Restraints
The worldwide market for plasma fractionation is relied upon to be driven by expanding frequencies of blood and invulnerable issue attributable to expanding maturing populace, alongside expanding off-name utilization of basic plasma items, for example, albumins, and immunoglobulins. However, heightening expenses of plasma subordinates and the hazard variables related with them, joined with expanding use of recombinant proteins and items going about as a substitute for the plasma items are required to limit the development of the worldwide plasma fractionation advertise during the conjecture time frame.
Regional Insights
North America overwhelmed the worldwide plasma fractionation showcase in 2017, because of expanding per capita medicinal services spending in the U.S., alongside rising interest from patients for better and propelled social insurance offices.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Kedrion S.p.A
- China Biologic Products, Inc.
- Grifols S.A
- LFB S.A
- Bio Product Laboratory Ltd.
- CSL Ltd.
- Baxalta Incorporated
- Octapharma AG
- Biotest AG
- Sanquin
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Plasma Fractionation Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o IVIG
o Albumin
o Factor VIII
o von Willebrand Factor
o PCC
o Protease Inhibitor
· Plasma Fractionation Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Immunology
o Hematology
o Critical Care
o Rheumatology
· Plasma Fractionation Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Clinic
o Academic Institute
· Plasma Fractionation Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Kedrion S.p.A
o China Biologic Products, Inc.
o Grifols S.A
o LFB S.A
o Bio Product Laboratory Ltd.
o CSL Ltd.
o Baxalta Incorporated
o Octapharma AG
o Biotest AG
o Sanquin
· Plasma Fractionation Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Plasma Fractionation Market, By Country
o U.S. Plasma Fractionation Market
o Canada Plasma Fractionation Market
o Mexico Plasma Fractionation Market
o Europe
§ Europe Plasma Fractionation Market, By Country
· Germany Plasma Fractionation Market
o UK Plasma Fractionation Market
o France Plasma Fractionation Market
o Russia Plasma Fractionation Market
o Italy Plasma Fractionation Market
o Rest of Europe Plasma Fractionation Market
o Asia-Pacific
§ Asia-Pacific Plasma Fractionation Market, By Country
o China Plasma Fractionation Market
o Japan Plasma Fractionation Market
o South Korea Plasma Fractionation Market
o India Plasma Fractionation Market
o Southeast Asia Plasma Fractionation Market
o Rest of Asia-Pacific Plasma Fractionation Market
o South America
§ South America Plasma Fractionation Market
o Brazil Plasma Fractionation Market
o Argentina Plasma Fractionation Market
o Columbia Plasma Fractionation Market
o Rest of South America Plasma Fractionation Market
o Middle East and Africa
§ Middle East and Africa Plasma Fractionation Market
o Saudi Arabia Plasma Fractionation Market
o UAE Plasma Fractionation Market
o Egypt Plasma Fractionation Market
o Nigeria Plasma Fractionation Market
o South Africa Plasma Fractionation Market
o Rest of MEA Plasma Fractionation Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Plasma Fractionation Market, By Product
5.1. Introduction
5.2. Global Plasma Fractionation Revenue and Market Share by Product (2017-2027)
5.2.1. Global Plasma Fractionation Revenue and Revenue Share by Product (2017-2027)
5.3. IVIG
5.3.1. Global IVIG Revenue and Growth Rate (2017-2027)
5.4. Albumin
5.4.1. Global Albumin Revenue and Growth Rate (2017-2027)
5.5. Factor VIII
5.5.1. Global Factor VIII Revenue and Growth Rate (2017-2027)
5.6. von Willebrand Factor
5.6.1. Global von Willebrand Factor Revenue and Growth Rate (2017-2027)
5.7. PCC
5.7.1. Global PCC Revenue and Growth Rate (2017-2027)
5.8. Protease Inhibitor
5.8.1. Global Protease Inhibitor Revenue and Growth Rate (2017-2027)
6. Plasma Fractionation Market, By Application
6.1. Introduction
6.2. Global Plasma Fractionation Revenue and Market Share by Application (2017-2027)
6.2.1. Global Plasma Fractionation Revenue and Revenue Share by Application (2017-2027)
6.3. Immunology
6.3.1. Global Immunology Revenue and Growth Rate (2017-2027)
6.4. Hematology
6.4.1. Global Hematology Revenue and Growth Rate (2017-2027)
6.5. Critical Care
6.5.1. Global Critical Care Revenue and Growth Rate (2017-2027)
6.6. Rheumatology
6.6.1. Global Rheumatology Revenue and Growth Rate (2017-2027)
7. Plasma Fractionation Market, By End User
7.1. Introduction
7.2. Global Plasma Fractionation Revenue and Market Share by End User (2017-2027)
7.2.1. Global Plasma Fractionation Revenue and Revenue Share by End User (2017-2027)
7.3. Hospital
7.3.1. Global Hospital Revenue and Growth Rate (2017-2027)
7.4. Clinic
7.4.1. Global Clinic Revenue and Growth Rate (2017-2027)
7.5. Academic Institute
7.5.1. Global Academic Institute Revenue and Growth Rate (2017-2027)
8. Plasma Fractionation Market, By Region
8.1. Introduction
8.2. Global Plasma Fractionation Revenue and Market Share by Regions
8.2.1. Global Plasma Fractionation Revenue by Regions (2017-2027)
8.3. North America Plasma Fractionation by Countries
8.3.1. North America Plasma Fractionation Revenue and Growth Rate (2017-2027)
8.3.2. North America Plasma Fractionation Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Plasma Fractionation by Countries
8.4.1. Europe Plasma Fractionation Revenue and Growth Rate (2017-2027)
8.4.2. Europe Plasma Fractionation Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Plasma Fractionation by Countries
8.5.1. Asia-Pacific Plasma Fractionation Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Plasma Fractionation Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Plasma Fractionation by Countries
8.6.1. South America Plasma Fractionation Revenue and Growth Rate (2017-2027)
8.6.2. South America Plasma Fractionation Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Plasma Fractionation by Countries
8.7.1. Middle East and Africa Plasma Fractionation Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Plasma Fractionation Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Kedrion S.p.A
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. China Biologic Products, Inc.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Grifols S.A
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. LFB S.A
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Bio Product Laboratory Ltd.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. CSL Ltd.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Baxalta Incorporated
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Octapharma AG
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Biotest AG
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Sanquin
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Plasma Fractionation Market Forecast (2017-2027)
10.1. Global Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Plasma Fractionation Market Forecast by Regions (2017-2027)
10.2.1. North America Plasma Fractionation Market Forecast (2017-2027)
10.2.1.1. United States Plasma Fractionation Market Forecast (2017-2027)
10.2.1.2. Canada Plasma Fractionation Market Forecast (2017-2027)
10.2.1.3. Mexico Plasma Fractionation Market Forecast (2017-2027)
10.2.2. Europe Plasma Fractionation Market Forecast (2017-2027)
10.2.2.1. Germany Plasma Fractionation Market Forecast (2017-2027)
10.2.2.2. France Plasma Fractionation Market Forecast (2017-2027)
10.2.2.3. UK Plasma Fractionation Market Forecast (2017-2027)
10.2.2.4. Russia Plasma Fractionation Market Forecast (2017-2027)
10.2.2.5. Italy Plasma Fractionation Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Plasma Fractionation Market Forecast (2017-2027)
10.2.3. Asia-Pacific Plasma Fractionation Market Forecast (2017-2027)
10.2.3.1. China Plasma Fractionation Market Forecast (2017-2027)
10.2.3.2. Japan Plasma Fractionation Market Forecast (2017-2027)
10.2.3.3. Korea Plasma Fractionation Market Forecast (2017-2027)
10.2.3.4. India Plasma Fractionation Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Plasma Fractionation Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Plasma Fractionation Market Forecast (2017-2027)
10.2.4. South America Plasma Fractionation Market Forecast (2017-2027)
10.2.4.1. Brazil Plasma Fractionation Market Forecast (2017-2027)
10.2.4.2. Argentina Plasma Fractionation Market Forecast (2017-2027)
10.2.4.3. Columbia Plasma Fractionation Market Forecast (2017-2027)
10.2.4.4. Rest of South America Plasma Fractionation Market Forecast (2017-2027)
10.2.5. Middle East and Africa Plasma Fractionation Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Plasma Fractionation Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Plasma Fractionation Market Forecast (2017-2027)
10.2.5.3. Egypt Plasma Fractionation Market Forecast (2017-2027)
10.2.5.4. Nigeria Plasma Fractionation Market Forecast (2017-2027)
10.2.5.5. South Africa Plasma Fractionation Market Forecast (2017-2027)
10.2.5.6. Turkey Plasma Fractionation Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Plasma Fractionation Market Forecast (2017-2027)
10.3. Plasma Fractionation Market Forecast by Product (2017-2027)
10.3.1. Plasma Fractionation Forecast by Product (2017-2027)
10.3.2. Plasma Fractionation Market Share Forecast by Product (2017-2027)
10.4. Plasma Fractionation Market Forecast by Application (2017-2027)
10.4.1. Plasma Fractionation Forecast by Application (2017-2027)
10.4.2. Plasma Fractionation Market Share Forecast by Application (2017-2027)
10.5. Plasma Fractionation Market Forecast by End User (2017-2027)
10.5.1. Plasma Fractionation Forecast by End User (2017-2027)
10.5.2. Plasma Fractionation Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Plasma Fractionation Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Plasma Fractionation Revenue and Revenue Share by Product (2017-2018)
Figure Global IVIG Revenue and Growth Rate (2017-2018)
Figure Global Albumin Revenue and Growth Rate (2017-2018)
Figure Global Factor VIII Revenue and Growth Rate (2017-2018)
Figure Global von Willebrand Factor Revenue and Growth Rate (2017-2018)
Figure Global PCC Revenue and Growth Rate (2017-2018)
Figure Global Protease Inhibitor Revenue and Growth Rate (2017-2018)
Table Global Plasma Fractionation Revenue and Revenue Share by Application (2017-2018)
Figure Global Immunology Revenue and Growth Rate (2017-2018)
Figure Global Hematology Revenue and Growth Rate (2017-2018)
Figure Global Critical Care Revenue and Growth Rate (2017-2018)
Figure Global Rheumatology Revenue and Growth Rate (2017-2018)
Table Global Plasma Fractionation Revenue and Revenue Share by End User (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Clinic Revenue and Growth Rate (2017-2018)
Figure Global Academic Institute Revenue and Growth Rate (2017-2018)
Table Global Plasma Fractionation Revenue by Regions (2017-2018)
Figure North America Plasma Fractionation Growth Rate (2017-2018)
Figure North America Plasma Fractionation Revenue and Growth Rate (2017-2018)
Figure North America Plasma Fractionation by Countries (2017-2018)
Figure North America Plasma Fractionation Revenue (Million USD) by Countries (2017-2018)
Figure United States Plasma Fractionation Growth Rate (2017-2018)
Figure United States Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Plasma Fractionation Growth Rate (2017-2018)
Figure Canada Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Plasma Fractionation Growth Rate (2017-2018)
Figure Mexico Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Plasma Fractionation Growth Rate (2017-2018)
Figure Europe Plasma Fractionation Revenue and Growth Rate (2017-2018)
Figure Europe Plasma Fractionation by Countries (2017-2018)
Figure Europe Plasma Fractionation Revenue (Million USD) by Countries (2017-2018)
Figure Germany Plasma Fractionation Growth Rate (2017-2018)
Figure Germany Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Plasma Fractionation Growth Rate (2017-2018)
Figure France Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Plasma Fractionation Growth Rate (2017-2018)
Figure UK Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Plasma Fractionation Growth Rate (2017-2018)
Figure Russia Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Plasma Fractionation Growth Rate (2017-2018)
Figure Italy Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Plasma Fractionation Growth Rate (2017-2018)
Figure Rest of Europe Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Plasma Fractionation Growth Rate (2017-2018)
Figure Asia-Pacific Plasma Fractionation Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Plasma Fractionation by Countries (2017-2018)
Figure Asia-Pacific Plasma Fractionation Revenue (Million USD) by Countries (2017-2018)
Figure China Plasma Fractionation Growth Rate (2017-2018)
Figure China Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Plasma Fractionation Growth Rate (2017-2018)
Figure Japan Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Plasma Fractionation Growth Rate (2017-2018)
Figure Korea Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Plasma Fractionation Growth Rate (2017-2018)
Figure India Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Plasma Fractionation Growth Rate (2017-2018)
Figure Southeast Asia Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Plasma Fractionation Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Plasma Fractionation Growth Rate (2017-2018)
Figure South America Plasma Fractionation Revenue and Growth Rate (2017-2018)
Figure South America Plasma Fractionation by Countries (2017-2018)
Figure South America Plasma Fractionation Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Plasma Fractionation Growth Rate (2017-2018)
Figure Brazil Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Plasma Fractionation Growth Rate (2017-2018)
Figure Argentina Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Plasma Fractionation Growth Rate (2017-2018)
Figure Columbia Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Plasma Fractionation Growth Rate (2017-2018)
Figure Rest of South America Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Plasma Fractionation Growth Rate (2017-2018)
Figure Middle East and Africa Plasma Fractionation Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Plasma Fractionation by Countries (2017-2018)
Figure Middle East and Africa Plasma Fractionation Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Plasma Fractionation Growth Rate (2017-2018)
Figure Saudi Arabia Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Plasma Fractionation Growth Rate (2017-2018)
Figure United Arab Emirates Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Plasma Fractionation Growth Rate (2017-2018)
Figure Egypt Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Plasma Fractionation Growth Rate (2017-2018)
Figure Nigeria Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Plasma Fractionation Growth Rate (2017-2018)
Figure South Africa Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Plasma Fractionation Growth Rate (2017-2018)
Figure Turkey Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Plasma Fractionation Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Plasma Fractionation Revenue (Millions USD) and Growth Rate (2017-2018)
Table Kedrion S.p.A Plasma Fractionation Financial Overview
Table China Biologic Products, Inc. Plasma Fractionation Financial Overview
Table Grifols S.A Plasma Fractionation Financial Overview
Table LFB S.A Plasma Fractionation Financial Overview
Table Bio Product Laboratory Ltd. Plasma Fractionation Financial Overview
Table CSL Ltd. Plasma Fractionation Financial Overview
Table Baxalta Incorporated Plasma Fractionation Financial Overview
Table Octapharma AG Plasma Fractionation Financial Overview
Table Biotest AG Plasma Fractionation Financial Overview
Table Sanquin Plasma Fractionation Financial Overview
Figure Global Plasma Fractionation Revenue (Millions USD) and Growth Rate (2018-2025)
Table Plasma Fractionation Market Forecast by Regions (2018-2025)
Figure North America Plasma Fractionation Market Forecast (2018-2025)
Figure United States Plasma Fractionation Market Forecast (2018-2025)
Figure Canada Plasma Fractionation Market Forecast (2018-2025)
Figure Mexico Plasma Fractionation Market Forecast (2018-2025)
Figure Europe Plasma Fractionation Market Forecast (2018-2025)
Figure Germany Plasma Fractionation Market Forecast (2018-2025)
Figure France Plasma Fractionation Market Forecast (2018-2025)
Figure UK Plasma Fractionation Market Forecast (2018-2025)
Figure Russia Plasma Fractionation Market Forecast (2018-2025)
Figure Italy Plasma Fractionation Market Forecast (2018-2025)
Figure Rest of Europe Plasma Fractionation Market Forecast (2018-2025)
Figure Asia-Pacific Plasma Fractionation Market Forecast (2018-2025)
Figure China Plasma Fractionation Market Forecast (2018-2025)
Figure Japan Plasma Fractionation Market Forecast (2018-2025)
Figure Korea Plasma Fractionation Market Forecast (2018-2025)
Figure India Plasma Fractionation Market Forecast (2018-2025)
Figure Southeast Asia Plasma Fractionation Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Plasma Fractionation Market Forecast (2018-2025)
Figure South America Plasma Fractionation Market Forecast (2018-2025)
Figure Brazil Plasma Fractionation Market Forecast (2018-2025)
Figure Argentina Plasma Fractionation Market Forecast (2018-2025)
Figure Columbia Plasma Fractionation Market Forecast (2018-2025)
Figure Rest of South America Plasma Fractionation Market Forecast (2018-2025)
Figure Middle East and Africa Plasma Fractionation Market Forecast (2018-2025)
Figure Saudi Arabia Plasma Fractionation Market Forecast (2018-2025)
Figure United Arab Emirates Plasma Fractionation Market Forecast (2018-2025)
Figure Egypt Plasma Fractionation Market Forecast (2018-2025)
Figure Nigeria Plasma Fractionation Market Forecast (2018-2025)
Figure South Africa Plasma Fractionation Market Forecast (2018-2025)
Figure Turkey Plasma Fractionation Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Plasma Fractionation Market Forecast (2018-2025)
Figure Global Plasma Fractionation Forecast by Product (2018-2025)
Figure Global Plasma Fractionation Market Share Forecast by Product (2018-2025)
Figure Global Plasma Fractionation Forecast by Product (2018-2025)
Figure Global Plasma Fractionation Forecast by Application (2018-2025)
Figure Global Plasma Fractionation Market Share Forecast by Application (2018-2025)
Figure Global Plasma Fractionation Forecast by Application (2018-2025)
Figure Global Plasma Fractionation Forecast by End User (2018-2025)
Figure Global Plasma Fractionation Market Share Forecast by End User (2018-2025)
Figure Global Plasma Fractionation Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|